Tumor induced hypoglycemia is seen in all , EXCEPT:
Tumor induced hypoglycemia Mesenchymal tumors, hemangiopericytomas, hepatocellular tumors, adrenal carcinomas produce excessive amounts of insulin-like growth factor type II (IGF-II) precursor, leading to insulin-like actions and hypoglycemia. Ref: Harrison,E-18,P-830
Mesenchymal tumors
Hepatocellular carcinoma
Adrenal carcinoma
Lymphoma